Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Happy Buy is a China-based e-commerce subsidiary established by Happiness Biotech Group to support online and cross-border commercialization rather than drug discovery or clinical development. The business has been described in public filings as a wholly owned subsidiary created to develop the parent company's e-commerce operations, including B2B, SaaS, and consumer sales activities. Its historical role appears tied to selling and distributing nutraceutical, dietary supplement, and related consumer products associated with the Happiness Biotech group. Based on the available evidence, Happy Buy is not itself a biotech or pharmaceutical developer, and there is no identifiable therapeutic pipeline, platform therapeutics engine, or clinical-stage asset portfolio under this entity. It is best understood as a commercial internet-technology and e-commerce operating subsidiary adjacent to, but distinct from, life sciences R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Happy Buy.